Prof. Dato’ Sri Dr. Mike K.S. Chan, 61, is a distinguished Researcher, Author, and Educator with a focus on Stem Cells, Peptides, Biologicals, and Regenerative Medicine. He is the esteemed founder of the European Wellness Biomedical Group in Germany, demonstrating his commitment to advancing medical wellness.

With an impressive portfolio, Dr. Chan holds ownership and co-ownership of 40 medical wellness facilities, diagnostics and youth restorative centers, hospitals, clinics, and R&D labs across Germany, the USA, Switzerland, the UK, Turkey, and Malaysia, fostering a global impact in healthcare provision and research. His prolific academic career spans over 40 scientific and medical books, complemented by more than 70 publications in the UK and USA. Dr. Chan's expertise is recognized through membership in over 20 esteemed academic bodies worldwide, coupled with an extensive portfolio of over 20 international patents in stem cells, immunology, and biotech.

He plays a pivotal role on the Board and leads the Scientific Committee for Regenerative Medicine at ESAAM (European Society of Preventative, Regenerative, and Anti-Aging Medicine) established in 2003. His influence extends further as he holds the Society’s Asian Chairmanship and holds an Associate Professorship at AASCP-USA (American Academy of Stem Cell Physicians). Additionally, Dr. Chan chairs A4M-USA (American Academy of Anti-Aging Medicine) for Thailand and chairs Japan’s Medical Association for Regenerative Medicine, MMJ (Multi-Dimensional Holistic Medical Team-Japan). He contributes as a Senator of BWAGermany (Federal Association for Economic Development & Foreign Trade for China, Indonesia, and Malaysia) and serves as a healthcare advisor to SSP (Swiss Strategic Partners) based in Zurich.

His collaborative efforts with eminent scientists, clinicians, and scholars in research and development have garnered him over 20 awards for leadership, entrepreneurship, quality assurance, and lifetime achievements globally. He is also a recipient of international invention awards in Biotechnology across Europe and the Middle East. Acknowledged among the Top 100 Influential or Prominent Chinese of the World, Dr. Chan’s contributions are exemplified by the recognition on stamps in the China Postal Office. His visibility extends to international magazine covers, notably in Chinese Foreign Trade Magazines for biotech.

In 2023, Dr. Chan's expertise was acknowledged by his appointment to a committee of 10 experts developing stem cell guidelines for Malaysia, a significant undertaking under the leadership of the Director General of Health in Malaysia.